Ceramide and its metabolic derivatives are important modulators of cellular apoptosis and proliferation. Dysregulation or imbalance of their metabolic pathways may promote the development of retinal degeneration. The aim of this study was to identify the expression and regulation of key enzymes of the ceramide pathway in retinal pigment epithelial (RPE) cells. RT-PCR was used to screen the enzymes involved in ceramide metabolism that are expressed in RPE. Over-expression of neutral sphingomyelinase-2 (SMPD3) or sphingosine kinase 1 (Sphk1) in ARPE-19 cells was achieved by transient transfection of SMPD3 or Sphk1 cDNA subcloned into an expression vector. The number of apoptotic or proliferating cells was determined using TUNEL and BrdU assays, respectively. Neutral sphingomyelinase-1, neutral sphingomyelinase-2, acidic ceramidase, ceramide kinase, SphK1 and Sphk2 were expressed in both ARPE-19 and early passage human fetal RPE (fRPE) cells, while alkaline ceramidase 2 was only expressed in fRPE cells. Over-expression of SMPD3 decreased RPE cell proliferation and increased cell apoptosis. The percentage of apoptotic cells increased proportionally with the amount of transfected SMPD3 DNA. Overexpression of SphK1 promoted cell proliferation and protected ARPE-19 cells from ceramide-induced apoptosis. The effect of C 2 ceramide on induction of apoptosis was evaluated in polarized vs. non-polarized RPE cultures; polarization of RPE was associated with much reduced apoptosis in response to ceramide. In conclusion, RPE cells possess the synthetic machinery for the production of ceramide, sphingosine, ceramide-1-phosphate (C1P), and sphingosine-1-phosphate (S1P). Over-expression of SMPD3 may increase cellular ceramide levels, leading to enhanced cell death and arrested cell proliferation. The selective induction of apoptosis in non-polarized RPE cultures by C 2 ceramide suggests that increased ceramide levels will preferentially affect non-polarized RPE, as are found in late age-related macular degeneration lesions, and may spare the normal RPE monolayer. SphK1 over-expression increased cellular S1P, which promoted cell proliferation and protected RPE from ceramide-induced apoptosis. Understanding the relationship between the metabolism of sphingolipids and their effects in RPE cell survival/death may help us to develop effective and efficient therapies for retinal degeneration.
Introduction
Data from clinical and basic research have provided evidence that apoptotic cell death plays a critical role in the pathogenesis of age-related macular degeneration (AMD) and other retinal degenerative diseases (Dorey, Wu, Ebenstein, Garsd, & Weiter, 1989; Sarks, 1976) . However, the etiology and mechanism of increased apoptosis in retinal pigment epithelial (RPE) cells in retinal degeneration remain largely unknown. Such knowledge concerning the mechanism of dysregulated apoptosis is critical because it may lead to new approaches for the prevention and treatment of these important disorders.
Ceramide is a central hub for sphingolipid metabolism; its breakdown or modification results in the production of several sphingolipids such as sphingosine, sphingosine-1-phosphate (S1P), and ceramide-1-phosphate (C1P) that, like ceramide itself, can potentially serve as both structural and/or cell signaling molecules (An, Yuhua Zheng, & Bleu, 2000; Cuvillier et al., 1996; Gulbins & Li, 2006; Ogretmen & Hannun, 2004; Taha, Mullen, & Obeid, 2006; Zheng et al., 2006) . In recent years, there has been an upsurge of interest in unraveling the roles of ceramide in the pathophysiology of different human diseases including neurodegenerative and retinal degenerative diseases. It is possible that targeted manipulation of the ceramide metabolic pathway may prove to be a novel strategy for treatment of neurodegenerative disease. Furthermore, in addition to apoptosis, ceramide has been suggested to play important roles in cell cycle arrest, inflammation, and the eukaryotic stress response (Gulbins & Kolesnick, 2003; Hannun & Luberto, 2000) . Although ceramide can be generated by de novo synthesis through ceramide synthase, for the majority of cellular responses, it is generated from sphingomyelin by the action of neutral or acid sphingomyelinase (Hannun, Luberto, & Argraves, 2001) .
Several sphingomyelinases (SMPDs) have been described in eukaryotes and prokaryotes and they are distinguished by their subcellular localization, pH optima, and requirement for metal ions (Hofmann, Tomiuk, Wolff, & Stoffel, 2000; Marchesini & Hannun, 2004) . To date, four SMPDs have been identified. The best characterized of these enzymes is the acid sphingomyelinase (SMPD1) that is predominantly located in lysosomes but also secreted in response to different ligand-receptor interactions at the cell surface (Schuchman, Suchi, Takahashi, Sandhoff, & Desnick, 1991) . A total of three neutral sphingomyelinases-SMPD2, SMPD3, and SMPD4-are localized in different cellular compartments and expressed in different tissues (Hofmann et al., 2000; Tomiuk, Hofmann, Nix, Zumbansen, & Stoffel, 1998) . SMPD2 is localized in the endoplasmic reticulum (ER) and expressed in all cell types (Zumbansen & Stoffel, 2002) . SMPD3 is expressed at highest levels in the brain, is activated by tumor necrosis factor a (TNFa), and contributes to TNFa-induced apoptosis in cultured cells (Clarke, Truong, & Hannun, 2007) . SMPD3-null mice have significant developmental defects, including dwarfism and delayed puberty (Stoffel, Jenke, Block, Zumbansen, & Koebke, 2005) . Stable over-expression of SMPD3 in MCF7 cells results in a markedly decreased growth rate at the late exponential phase, suggesting that SMPD3 is involved in the regulation of the cell cycle (Marchesini, Luberto, & Hannun, 2003) . SMPD4 is localized in the ER as well as in the Golgi, and has been shown to be activated in response to TNFa, although its physiological role has yet to be defined (Krut, Wiegmann, Kashkar, Yazdanpanah, & Kronke, 2006) . SphKs are critical enzymes that regulate the cellular levels of S1P and thus ultimately control cell fate. SphKs are ubiquitously expressed and exist in two subtypes, SphK1 and SphK2 (Alemany et al., 2007; Bryan, Kordula, Spiegel, & Milstien, 2008) . SphK1 has major roles in cell proliferation and migration and is expressed in different tumors (Alemany et al., 2007) . Recent studies implicate endogenous SphK1 as an important survival enzyme. Knocking down the Sphk1 expression by siRNA gene silencing could cause cell cycle arrest and induce apoptosis by the activation of caspases and the oligomerization of Bax on the mitochondrial membrane (Taha et al., 2006) . SphK2, on the other hand, has different properties and subcellular locations from Sphk1. Although Sphk1 and Sphk2 are able to complement each other for some key functions, Sphk2 has distinct biological functions, and even has opposing roles in the regulation of cell fate. It has been reported that Sphk2 has pro-apoptotic function and the over-expression of SphK2 in various cell types blocks DNA synthesis (Igarashi et al., 2003; Liu et al., 2003) .
Our laboratory recently established that oxidative stress induced by exogenous ceramide leads to apoptosis in human RPE cells and that this effect could be partially prevented by growth factors and antioxidants (Kannan, Jin, Gamulescu, & Hinton, 2004; Sreekumar, Ding, Ryan, Kannan, & Hinton, 2009 ). However, the precise mechanisms of the cellular action of ceramide and the enzymes that are involved in the sphingolipid pathway in RPE have not been fully explored. Expression and regulation of sphingolipid metabolizing enzymes in the RPE has not been hitherto studied. Because neutral SMPD3 and SphK1 were highly expressed in RPE cells and have opposing functions for evaluating their roles in mediating cell fate, we focused on the regulation and function of SMPD3 and SphK1 in RPE. Our data shows that over-expression of SMPD3 induced RPE cell death and inhibited cell proliferation, whereas over-expression of SphK1 induced cell proliferation and protected RPE cells from cell death after C 2 ceramide exposure. (Sonoda et al., 2009 ). The fRPE cells were then cultured in DMEM supplemented with 100 U/mL penicillin-streptomycin, 2 mM L-glutamine, and 10% FBS. The fRPE cells used for experiments at passage 3 or 4. C. Polarized fRPE cell culture: Passage 1 human fRPE cells (2 Â 10 5 for each well) were seeded on fibronectin-coated transwell membranes, and cultured in RPE medium with 1% FBS as previously described (Sonoda et al., 2009 ). The formation of tight junctions among the cells was determined by measuring the trans-epithelial resistance (TER) with an EVOM epithelial tissue voltohmmeter. Polarized fRPE cells with a resistance of >170 X cm 2 were used in our study.
Methods

Cell culture
Cell treatment
A. GW4869 treatment: After transient transfection for 24 h, the SMPD3 overexpressed or vector only control ARPE-19 cells were treated with 20 lM GW4869, a specific neutral sphingomyelinase inhibitor (Luberto et al., 2002) 
Conventional RT-PCR
Total RNA was extracted from SMPD3, SphK1, pcDNA3.1 vector only transfected ARPE-19 cells using TRIzol reagent (Invitrogen, Carlsbad, CA) and quantified with a spectrophotometer. The first strand cDNA was synthesized from 1 lg total RNA with a cDNA synthesis kit as per manufacturer's protocol (Promega, Madison, WI). The detection of the ceramide metabolic pathway enzymes was achieved by PCR amplification using specific primers with a PCR kit (Qiagen, Valencia, CA). GAPDH was used as an internal loading control. Specificity of the reaction was verified with no-template negative control. The specific primer pairs used in screening enzymes of the ceramide pathways by RT-PCR are listed in Table 1 .
Western blot analysis
SphK1 overexpressing and control ARPE-19 cells were homogenized in RIPA buffer (50 mM Tris-HCl, pH8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate and 0.1% SDS) with 1X protease inhibitor cocktail (Sigma). Equal amounts of protein from each sample (10 lg/well) underwent electrophoresis on 10% polyacrylamide gels and were electrically transferred to a PVDF membrane (Millipore Corp, Jeffery, NH). A rabbit anti-SphK1 polyclonal antibody (1:1000 dilution; Cayman Chemical, Ann Arbor, MI) was used to detect the expression levels of the SphK1 protein. Quantification of the SphK1 protein was made by measuring band intensity and area using Scion software (NIH) and normalized to GAPDH.
TUNEL assay
A. Quantitative measure of apoptotic cells: The cells were collected by trypsinization and fixed with 2% paraformaldehyde in PBS pH 7.4. Apoptotic cells were labeled using the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-fluorescein nick end-labeling (TUNEL) cell death detection kit (Roche, IN) according to the manufacturer's instructions, and quantitated by flow cytometric analysis. B. In situ staining of apoptotic cells: Polarized and non-polarized confluent fRPE cells were treated with 25 lM C 2 ceramide for 24 h in 1% serum containing culture medium. The treated cells were then fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 and 0.1% sodium citrate, and incubated with TdT enzyme mixture using a cell death detection kit (Roche, IN). The number of TUNEL positive cells were counted under a fluorescent microscope and presented as the percentage of dead cells.
BrdU incorporation assay
After being transiently transfected with varying quantities of SMPD3 cDNA, SphK1 cDNA or vector only for 24 h, the transfected ARPE-19 cells were trypsinized, re-seeded on chamber slides or 96-well plates and continued to be cultured for 16 h. The cells were then treated with BrdU (10 lM) for 6 h. The BrdU incorporation rates of control and transfected cells were measured with the BrdU Incorporation Assay Kit (Roche, IN) by in situ BrdU immunostaining, or by cell proliferation ELISA according to the manufacturer's instructions.
Statistical analysis
Data presented represent mean + SD. ANOVA was used to identify the global differences on data collected from TUNEL and BrdU incorporation assays. Multiple pairwise comparisons with Tukey adjustment were performed to test the differences between the effects of inhibitor treated and non-treated SMPD3 overexpressing cells or C 2 ceramide treated and non-treated Sphk1 overexpressing cells. All p-values reported were 2-sided, and p < 0.05 was considered statistically significant.
Results
Expression of sphingolipid metabolizing enzymes in ARPE-19 and fRPE cells
Understanding the expression of the spectrum and dominant isoforms of the sphingolipid metabolic pathway enzymes in RPE cells can help us determine which enzymes participate in the sphingolipid metabolism in RPE cells. We screened the sphingolipid metabolic pathway enzymes with RT-PCR amplification, Table 1 Primer pairs used to amplify enzymes involved in ceramide metabolic pathway.
Name of genes
Forward (F)/Reverse (R) Length of amplified cDNA Primer sequences
and found that neutral sphingomyelinase 1 (SMPD2), and neutral sphingomyelinase 2 (SMPD3), acidic ceramidase (ASAH1), ceramide kinase (CERK) and sphingosine kinases (SphKs) were expressed in both ARPE-19 and human fRPE cells, while alkaline ceramidase 2 (ACER2) was only expressed in fRPE (Fig. 1) . Acidic sphingomyelinase (SMPD1), alkaline ceramidase 1 (ACER1), neutral ceramidase (ASAH2) and ceramide kinase-like (CERKL) were not detectable in the RPE cells with RT-PCR.
Over-expression of SMPD3 renders ARPE-19 cells more susceptible to apoptosis
Increased ceramide levels have been shown to induce cell cycle arrest, apoptosis and cell differentiation (Hannun & Luberto, 2000) . In order to assess whether the effects of changes in cellular sphingolipid content would modulate the RPE cell fate, we increased the expression of SMPD3 or SphK1 by transient transfection of SMPD3 and Sphk1 expression vectors into ARPE-19 cells and measured the changes in the rate of RPE cell death and growth. The over-expression of transcripts for SMPD3 and Sphk1, and protein for Sphk1 in ARPE-19 cells was confirmed by RT-PCR and western blot, respectively ( Fig. 2A and B) .
SMPD3-overexpressing ARPE-19 cells exhibited significantly increased apoptosis with serum starvation as compared to vector only controls (46% vs. 4%, respectively, p < 0.01, Fig. 3 ). ARPE-19 cells transfected with increasing amounts of SMPD3 DNA showed a dose-dependent increase in apoptotic cells as evident by TUNEL assay. To confirm that the apoptosis was truly induced by the increased SMPD3 expression in ARPE-19 cells, we introduced GW4869, a neutral sphingomyelinase inhibitor, into SMPD3 overexpressing cells. The apoptotic RPE cells were significantly reduced by pre-treatment with 20 lM GW4869 in all SMPD3 overexpressing cells transfected with different DNA concentrations (p < 0.05) (Fig. 4) .
SphK1-overexpressing cells are resistant to apoptosis after oxidative insult
Sphk1 is an important enzyme for the formation of S1P, which functions as an extracellular or intracellular messenger that modulates cell fates, including the suppression of apoptosis and the increase of cell proliferation . To verify the function of Sphk1 in RPE cells, we overexpressed Sphk1 in ARPE-19 cells by the transient transfection of Sphk1 expression vector. The percentage of apoptotic cells in the SphK1-overexpressing cells was similar to the vector only controls. We then challenged the SphK1-overexpressing cells with 25 lM C 2 ceramide and measured the number of apoptotic cells by flow cytometric analysis of TUNELstained cells. About 36% of cells underwent apoptosis in the vector only control group with C 2 ceramide-induced oxidative stress, while a dose-dependent decrease in cell death was observed in SphK1 transfected cells (Fig. 5) . Only 10% cell death was observed in cells transfected with 0.5 lg SphK1 DNA (p < 0.01), suggesting its protective role in ceramide-induced oxidative stress in ARPE-19 cells.
SMPD3 and SphK1 have an opposing effect on cell proliferation in ARPE-19 cells
To understand whether SMPD3 and Sphk1 have opposing effects on RPE proliferation, we overexpressed SMPD3 or Sphk1 in ARPE-19 cells by transient transfection with different amounts of SMPD3 or Sphk1 expression plasmids (0.1-1 lg) and treated these overexpressed cells with BrdU for 6 h. The BrdU incorporation result showed significantly decreased BrdU uptake by SMPD3-overexpressing cells even at the lowest amount of transfected DNA (0.1 lg) (p < 0.05) compared to the vector only control cells (Fig. 6A) , while SphK1 over-expression, on the other hand, significantly increased BrdU incorporation in a dose-dependent manner in RPE cells. This indicates that SMPD3 inhibits RPE cell proliferation through hydrolysis of sphingomyelin to produce ceramide, and Sphk1 has the opposite function to increase RPE cell proliferation, possibly through phosphorylating sphingosine to form S1P (Fig. 6A and B) . Table 1 ). SMPD2, SMPD3, ASAH1, CERK and Sphks are expressed in both ARPE-19 and fRPE cells. ACER2 is only expressed in fRPE cells. Lane 1, DNA marker; 2, acid sphingomyelinase (SMPD1); 3, neutral sphingomyelinase 1(SMPD2); 4, neutral sphingomyelinase 2 (SMPD3); 5, acid ceramidase (ASAH1); 6, alkaline ceramidase 1 (ACER1); 7, alkaline ceramidase 2 (ACER2); 8, neutral ceramidase (ASAH2); 9, ceramide kinase (CERK); 10, ceramide kinase like (CERKL); 11, sphingosine kinase 1 (SphK1); 12, sphingosine kinase 2 (SphK2); 13, GAPDH; 14, negative control. 
Polarized and non-polarized RPE have differential susceptibility to ceramide treatment
To examine whether the upregulation of cellular ceramide might induce cell death in the normal RPE monolayer in vivo, we used highly polarized RPE cells, grown on transwell membranes to mimic the in vivo situation, and non-polarized confluent RPE cells, grown on chamber slides as a representation of activated RPE such as those found in AMD lesions, or in epiretinal membranes such as those found in proliferative vitreoretinopathy (PVR) (Campochiaro, Kaden, Vidaurri-Leal, & Glaser, 1985; Hinton, He, & Lopez, 1998) . Polarity of RPE monolayer was confirmed by measurement of trans-epithelial resistance (TER); mean resistance measured 170 ± 9.5 X cm 2 and did not change significantly after 24-h C 2 ceramide treatment. About 23% cell death was observed in non-polarized RPE cells subjected to 24 h ceramide treatment, while less than 2% cell death was observed in polarized cultures, indicating that the normal RPE monolayer in vivo may have more resistance to ceramide challenge than activated RPE such as those found in AMD lesions or in PVR (p < 0.001) ( Fig. 7A and B) .
Discussion
Apoptosis, or programmed cell death, plays a critical role in the pathogenesis of many blinding diseases, including the late stages of AMD (Beatty, Koh, Phil, Henson, & Boulton, 2000; Hinton et al., 1998) . Understanding the causes and mechanisms of such degenerative disorders will help us to devise new approaches to prevent and treat these diseases. The association between intracellular ceramide production and oxidative injury has been well established. Ceramide plays a critical role in apoptosis, proliferation, cellular senescence, and gene regulation through modulation of a variety of protein kinases and phosphatases and activation of transcription factors such as NFkappaB (Ruvolo, 2003) . The close link between reactive oxygen species (ROS) generation, sphingolipid metabolism and ceramide production has been investigated in several cell types that include RPE, retinal pericytes and photoreceptors (Barak, Morse, & Goldkorn, 2001; Cacicedo, Benjachareowong, Chou, Ruderman, & Ido, 2005; Denis et al., 2002; Kannan et al., 2004; Mansat-deMas et al., 1999) . It was reported that ceramide-induced oxidative stress by increasing ROS generation or by inhibiting the ROS scavenger glutathione in lung epithelial cells (Laventriadou et al., 2001) . Any dysregulation or imbalance of ceramide or its metabolic products could play a role in the development of apoptosis and disease states such as retinal degeneration (Acharya et al., 2003; Obeid, Linardic, Karolak, & Hannun, 1993; Tuson, Marfany, & Gonzalez-Duarte, 2004) .
Ceramide and its metabolic products are generated by a series of enzymatic reactions. The multiple routes of generation and removal of ceramide and its derivates exist in a variety of cell types (Gulbins & Li, 2006) . To better understand the ceramide metabolic pathway in RPE cells, we screened the expression of ceramide metabolic pathway enzymes and found that SMPD2, SMPD3, ASAH1, CERK and Sphks were expressed in both ARPE-19 and human fRPE cells indicating that some, but not all, ceramide metabolic pathways, exist in RPE. Our data suggested that RPE cells may utilize The percentage of apoptotic cells was measured by TUNEL stain followed by flow cytometry. The result shows that SphK1 transfection significantly decreased the number of apoptotic cells upon challenge with ceramide in a dose-dependent manner compared to vector only control cells ( Ã p < 0.05; ÃÃ p < 0.01, ANOVA). Mean data from at least three independent experiments is presented. SMPD2 and SMPD3 to catalyze sphingomyelin for ceramide generation, ASAH1 to cleave ceramide to form sphingosine, or CERK to phosphorylate ceramide to become C1P, and Sphks, mainly Sphk1, to phosphorylate sphingosine to form S1P. Thus, RPE cells can generate ceramide and sphingosine, which have been demonstrated to induce cell cycle arrest and apoptosis, and can also generate C1P and S1P, which act as antagonists of ceramide and sphingosine to promote cell proliferation and protect cells from a variety of insults.
To establish the association between altered metabolic pathways of major sphingolipids and dysfunction of retinal cells, we artificially manipulated the sphingolipid metabolic pathways by over-expression of specific enzymes in the ceramide pathway, and examined the causal influence of these modulations on the morphology, cell death and survival of RPE in vitro. In this study, we evaluated the induction of apoptosis and cell proliferation after over-expression of SMPD3 or SphK1 in ARPE-19 cells. Our data are consistent with the view that these ceramide metabolic enzymes have opposing functions in regard to cell survival and proliferation; SMPD3 is pro-apoptotic and anti-proliferative, while SphK1 promotes cell proliferation, with no significant change in % apoptosis when compared to vector only control cells. Since these experiments do not address rescue of individual cells, the overall effect of SphK1 over-expression may be due to shifting the balance toward cell proliferation.
In recent years increased attention has been given to neutral sphingomyelinase for its multiple roles in modulating an array of cellular processes such as cell cycle arrest, cell differentiation and apoptosis through the generation of ceramide (Hannun & Luberto, 2000) . Our data revealed that SMPD3 overexpressing cells are highly susceptible to apoptosis under serum deprivation conditions, suggesting that ceramide accumulation in cells may be inducing cell death. In support of this view, overexpressing SMPD3 in a human breast cancer cell line, MCF-7, increased cell death induced by the anti-cancer drug daunorubicin, and overexpressing SMPD3 in a human oligodendroglioma derived cell line, HOC, also enhanced cell death induced by staurosporine (Goswami et al., 2005; Ito et al., 2009 ). Under our experimental conditions, we found a 25% decrease in cell proliferation rate in SMPD3-overexpressing vs. vector only control ARPE-19 cells, which is similar to the findings in SMPD3-overexpressing MCF7 cells, although different assays were used in the two studies (Marchesini et al., 2003) . The biological significance of the role of SMPD3 on the inhibition of cell proliferation needs to be established by further work.
To confirm that the cell death and cell growth arrest were induced by increased SMPD3 expression that, in turn, resulted in increased cellular ceramide level, we inhibited SMPD3 by incubating ARPE-19 cells with GW4869 and found a significant increase in cell proliferation associated with a significant decrease in cell death, which could be attributed to a decrease in ceramide levels. However, GW4869 could not completely prevent the cell death induced by over-expression of SMPD3. The reason for this incomplete, but significant, inhibition of cell death by GW4869 is most likely because, although GW4869 can completely inhibit cellular neutral sphingomyelinase activity in vitro, it only partially prevents the release of cytochrome c from mitochondria (Luberto et al., 2002) . It has been demonstrated that ceramide exerts a direct effect on mitochondria to produce reaction oxygen species (ROS), eventually leading to mitochondrial dysfunction and the release of cytochrome c and Bax to induce apoptosis (Garcia-Ruiz, Colell, Mari, Morales, & Fernandez-Checa, 1997; Quillet-Mary et al., 1997). It is unclear why GW4869 only partially blocks cytochrome c release Sphingosine kinases (SphKs) are key enzymes regulating the production of S1P, which determines important cellular responses, including cell growth and apoptosis (Hait, Oskeritzian, Paugh, Milstien, & Spiegel, 2006) . Our data shows that the over-expression of SphK1 renders cells more resistant to ceramide-induced cell death, with 45% less apoptotic cells observed in SphK1-overexpressing cells that those in vector only control cells. This may arise from a decline in cellular ceramide levels that could trigger apoptotic signaling. A number of studies in various cell types revealed that the over-expression of SphK1 and increased S1P production promote cell growth, enhance the G1/S transition and increase cells in S-phase (Olivera et al., 1999) . Furthermore, siRNA mediated gene silencing of SphK1 markedly decreased cell proliferation in glioblastoma cells and increased cell death (Van Brocklyn et al., 2005) . The precise mechanisms of SphK1 action in RPE remain to be elucidated.
Our previous work had suggested indirectly that increased ceramide levels might differentially affect polarized RPE, as are found in the normal RPE monolayer, as opposed to non-polarized RPE, as are found in late AMD lesions (Sreekumar et al., 2008; Vogt et al., 2009) . To directly test this hypothesis, we evaluated the effect of C 2 ceramide on polarized human RPE cultures in comparison to non-polarized cultures and indeed, found that polarized RPE cultures were much more resistant to the apoptotic effects of C 2 ceramide. This suggests that increased ceramide levels may have more profound effects at the site of late AMD lesions where it may promote the progression of the disease by increasing apoptosis.
In summary, we report for the first time the pattern of expression of several ceramide metabolizing enzymes in ARPE-19 cells and early passage fRPE. The role of SMPD3 and SphK1 in cell proliferation and cell death was also studied. SMPD3-overexpressing cells were found to be highly susceptible to cell death even without oxidant injury and exhibited a decrease in cell proliferation. On the other hand, SphK1 was antiapoptotic and protected ARPE cells from ceramide-induced oxidative injury. Furthermore, the proliferation rate of SphK1-overexpressing cells was significantly higher than that of control cells. These findings are likely to have some clinical applications. For example, it was shown that oxidized low density lipoproteins (oxLDL) accumulate in AMD lesions in vivo, and induce significant increases of sphingomyelin, ceramides and cholesteryl esters in ARPE-19 cells in vitro (Yamada et al., 2008) . Further, neutral ceramidase was shown to rescue photoreceptor degeneration in Drosophila, while the inhibition of ceramide synthesis prevented paraquat-induced cell death in rat photoreceptor cultures (Acharya et al., 2003; German, Miranda, Abrahan, & Rotstein, 2006) . Recently, anti-sphingosine-1-phosphate monoclonal antibodies have been shown to inhibit retinal and choroidal angiogenesis in mice (Caballero et al., 2009; Xie et al., 2009 ). Thus, our present work in RPE, in conjunction with the above mentioned function of ceramide pathway in photoreceptor cell death and rescue, points to a potential therapeutic use of regulators of ceramide metabolism in treatment of retinal degenerative diseases.
